TY - JOUR
TI - Ofatumumab for B cell chronic lymphocytic leukaemia
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2015
ET - 2015/04/20
VL - 38
IS - 4
SP - 141
EP - 142
DO - 10.18773/austprescr.2015.052
LA - eng
UR - https://australianprescriber.tg.org.au/articles/ofatumumab-for-b-cell-chronic-lymphocytic-leukaemia.html
KW - Arzerra
KW - ofatumumab
KW - B-cell chronic lymphocytic leukaemia
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -